000 | 01052 a2200313 4500 | ||
---|---|---|---|
005 | 20250515073114.0 | ||
264 | 0 | _c20070810 | |
008 | 200708s 0 0 eng d | ||
022 | _a1542-6270 | ||
024 | 7 |
_a10.1345/aph.1H451 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aChamberlin, Kevin W | |
245 | 0 | 0 |
_aOral oxymorphone for pain management. _h[electronic resource] |
260 |
_bThe Annals of pharmacotherapy _cJul 2007 |
||
300 |
_a1144-52 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Review | ||
650 | 0 | 4 | _aAdministration, Oral |
650 | 0 | 4 | _aDelayed-Action Preparations |
650 | 0 | 4 | _aDisease Management |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aOxymorphone _xadministration & dosage |
650 | 0 | 4 |
_aPain _xdrug therapy |
650 | 0 | 4 |
_aPain Measurement _xdrug effects |
700 | 1 | _aCottle, Mark | |
700 | 1 | _aNeville, Rebecca | |
700 | 1 | _aTan, Jennifer | |
773 | 0 |
_tThe Annals of pharmacotherapy _gvol. 41 _gno. 7 _gp. 1144-52 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1345/aph.1H451 _zAvailable from publisher's website |
999 |
_c17132074 _d17132074 |